Boston's early-stage biotech industry is growing up. Here's the proof.

Biotechs dominate the list of companies with fastest-growing revenues, but only in a handful of cases does the revenue come from companies that sell they’re own product.

State lowers requirements for MassHealth patients to get hep C drugs

Massachusetts has lowered the requirements to qualify for hepatitis C drugs and forged agreements with two drugmakers to lower the price.

​Tesaro raises $377M in largest local biotech stock offering in past year

The secondary offering is the largest to be raised by a local biotech company since the sector began a significant selloff nearly a year ago.

Two IPOs bring Bay State’s total for 2016 nine. Here’s a recap.

All told, the nine Massachusetts based companies made up 22 percent of the 41 companies worldwide that held IPOs on U.S. markets since Jan. 1.

Boston Business Journal Science & Tech Newsletters